Silver Book Fact

The prevalence of age-related macular degeneration (AMD) in the 40 and older population has decreased from an estimated 9.4% from 1988 to 1994, to 6.5% for 2005 to 2008.

Klein, Ronald, Chiu-Fang Chou, Barbara E. K. Klein, Xinzhi Zhang, Stacy M. Meuer, and Jinan B. Saadine. Prevalence of Age-Related Macular Degeneration in the U.S. Population. Arch Ophthalmol. January 2011; 129(1): 75-80. http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=3&cts=1330977849323&ved=0CDoQFjAC&url=http%3A%2F%2Farchopht.ama-assn.org%2Fcgi%2Fcontent%2Ffull%2F129%2F1%2F75&ei=NhxVT7f9N8W30AHSq6C8DQ&usg=AFQjCNGXJ3281XFLb-OelB4n3njSRegX2g

Reference

Title
Prevalence of Age-Related Macular Degeneration in the U.S. Population
Publication
Arch Ophthalmol
Publication Date
January 2011
Authors
Klein, Ronald, Chiu-Fang Chou, Barbara E. K. Klein, Xinzhi Zhang, Stacy M. Meuer, and Jinan B. Saadine.
Volume & Issue
Volume 129, Issue 1
Pages
75-80
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • After 54 weeks of receiving bevacizumab, wet age-realted macular degeneration (AMD) patients were more likely to gain at least 6 letters of contrast sensitivity than patikents recieving standard care–35.4% versus…  
  • Gene transfer process treatment for diabetic retinopathy
    A gene transfer process that produces a VEGF receptor prevents retinal vascular permeability (RVP) associated with diabetes that could have value in treating diabetic retinopathy.  
  • The cost-effectiveness of detection and treatment of eye disease in diabetics is $3,190 per quality adjusted life year (QALY).  
  • Omega-3 polyunsaturated fatty acids have been found to protect against the development and progression of deterioration of the retina (retinopathy).  
  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of 94,304 person-years of sight.